Table 3 DSS by patient characteristics with Cox and Log normal analysis1
Group A – Low risk characteristics: (complete resection, hemoglobin: ≥ 100 for both sexes, no lymph node involvement, no SVC obstruction) | |||
|---|---|---|---|
Estimated disease-specific survival probabilities (in per cent, with 95% confidence intervals, CI) at 1, 3, and 5 years by different methods | |||
Methods: | 1 | 3 | 5 |
Cox | 94 (87,97) | 65 (38,82) | 58 (31,78) |
Log-normal survival analysis | 98 (87,99.9) | 82 (46,97) | 64 (26,92) |
Group B – Intermediate risk #1: (incomplete or no resection, hemoglobin: ≥ 100 for both sexes, no lymph node involvement, no SVC obstruction) | |||
Estimated disease-specific survival probabilities (in per cent, with 95% confidence intervals, CI) at 1, 3, and 5 years by different methods | |||
Methods: | 1 | 3 | 5 |
Cox | 91 (85,95) | 52 (33,68) | 45 (26,62) |
Log-normal survival analysis | 95 (77,99) | 67 (32,91) | 45 (16,78) |
Group C – Intermediate risk #2: (incomplete or no resection, hemoglobin: < 100 for both sexes, no lymph node involvement, no SVC obstruction) | |||
Estimated disease-specific survival probabilities (in per cent, with 95% confidence intervals, CI) at 1, 3, and 5 years by different methods | |||
Methods: | 1 | 3 | 5 |
Cox | 78 (31,95) | 16 (0,67) | 11 (0,62) |
Log-normal survival analysis | 84 (55,97) | 42 (14,76) | 23 (5,56) |
Group D – High risk characteristics: (no resection, hemoglobin: < 100 for both sexes, lymph node involvement, SVC obstruction) | |||
Estimated disease-specific survival probabilities (in per cent, with 95% confidence intervals, CI) at 1, 3, and 5 years by different methods | |||
Methods: | 1 | 3 | 5 |
Cox | 66 (19,90) | 5 (0,48) | 3 (0, 41) |
Log-normal survival analysis | 67 (27,93) | 22 (4,40) | 9 (1,38) |